BILL vs BSX · rev $1.65B vs P/E 20, rev $10.65B
Bill Com Holdings Inc (BILL) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
BILL currently screens at market cap $4.78B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the BILL and BSX stock pages for the full models.
Not investment advice.